Lee Ainslie - Maverick Capital
Holding/activity history for  Ultragenyx Pharma. Inc. (RARE)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2021   Q4 | 0 | 0 | Sell 100.00% | 0.01 | |
2021   Q3 | 5,861 | 0.01 | Reduce 42.38% | 0.01 | $90.26 |
2021   Q2 | 10,172 | 0.01 | Reduce 8.96% | 0.00 | $95.36 |
2021   Q1 | 11,173 | 0.01 | Buy | 0.01 | $113.85 |